The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
23ANDME HOLDING CO CLASS A COM 90138Q108   10,014,700 10,243,122 SH   SOLE   10,243,122 0 0
ALECTOR INC COM 014442107   8,474,920 1,307,858 SH   SOLE   1,307,858 0 0
FOGHORN THERAPEUTICS INC COM 344174107   7,868,805 1,573,761 SH   SOLE   1,573,761 0 0
ISHARES TR MSCI INDIA ETF 46429B598   107,239,868 2,425,144 SH   SOLE   2,425,144 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105   1,061,620 992,168 SH   SOLE   992,168 0 0
ORIC PHARMACEUTICALS INC COM 68622P109   5,985,931 989,410 SH   SOLE   989,410 0 0
PMV PHARMACEUTICALS INC COM 69353Y103   16,133,728 2,627,643 SH   SOLE   2,627,643 0 0
RAPT THERAPEUTICS INC COM 75382E109   10,934,281 657,899 SH   SOLE   657,899 0 0
SPDR GOLD TR GOLD SHS 78463V107   182,165,625 1,062,500 SH   SOLE   1,062,500 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103   105,266,950 246,250 SH   SOLE   246,250 0 0
SURROZEN INC COM 86889P109   393,452 802,963 SH   SOLE   802,963 0 0
TENAYA THERAPEUTICS INC COM 87990A106   2,590,048 1,015,705 SH   SOLE   1,015,705 0 0